What is Cobicistat-elvitegravir-emtricitabine-tenofovir alafenamide?

Category: Prescription Drugs

Most popular types: Genvoya

false

This is a combination medication of antiretrovirals may be used for treatment of HIV.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
2
None
2

Commonly reported side effects and conditions associated with Cobicistat-elvitegravir-emtricitabine-tenofovir alafenamide

Side effect Patients
Chronic kidney disease 1
Diarrhea 1
Elevated liver enzymes 1

Dosages

Based on patients currently taking Cobicistat-elvitegravir-emtricitabine-tenofovir alafenamide

Dosage Patients
150-150-200-10 mg daily 8
1 tablet(s) daily 3

Duration

Currently taking Cobicistat-elvitegravir-emtricitabine-tenofovir alafenamide

Duration Patients
1 - 6 months 1
1 - 2 years 9
2 - 5 years 1
Adherence
Adherence Evaluations
Always 4
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 4
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 1
< $25 2
Not specified 1

What people switch to and from

Patients started taking Cobicistat-elvitegravir-emtricitabine-tenofovir alafenamide after stopping:

Treatment Patients
Cobicistat-elvitegravir-emtricitabine-tenofovir disoproxil (Stribild) 6
Emtricitabine-Tenofovir (Truvada) 2
Abacavir-lamivudine (Epzicom) 1
Efavirenz-Emtricitabine-Tenofovir (Atripla) 1
Rilpivirine-Tenofovir-Emtricitabine (Complera) 1

Show all 7 treatments patients report switching from

Last updated:
There are no evaluations for Cobicistat-elvitegravir-emtricitabine-tenofovir alafenamide.